These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 383103)

  • 1. Accelerated remission of the alcoholic organic brain syndrome with EMD 21657. Double-blind clinical and psychometric trials.
    Saletu M; Grünberger J; Saletu B; Mader R
    Arzneimittelforschung; 1978; 28(9):1525-7. PubMed ID: 383103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of the alcoholic organic brain syndrome with EMD 21657. A derivative of a pyritinolmetabolite: double-blind clinical, quantitative EEG and psychometric studies.
    Saletu B; Grünberger J; Saletu M; Mader R; Volavka J
    Int Pharmacopsychiatry; 1978; 13(3):177-92. PubMed ID: 355183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
    Herrmann WM; Kern U; Röhmel J
    Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution to the search for vigilance-indicative EEG variables. Results of a controlled, double-blind study with pyritinol in elderly patients with symptoms of mental dysfunction.
    Herrmann WM; Kern U; Röhmel J
    Pharmacopsychiatry; 1986 Mar; 19(2):75-83. PubMed ID: 3517890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of Ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo].
    Hofferberth B
    Arzneimittelforschung; 1989 Aug; 39(8):918-22. PubMed ID: 2684175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
    Cooper AJ; Magnus RV
    Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the organic brain syndrome in the elderly. A double-blind comparison on the effects of a neurotropic drug and placebo.
    Noël G; Jeanmart M; Reinhardt B
    Neuropsychobiology; 1983; 10(2-3):90-3. PubMed ID: 6371575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pyrithioxin (Encephabol) in the treatment of patients with organic psychosyndrom in involution. Clinical, EEG and experimental psychological study (author's transl)].
    Misurec J; Sláma B; Náhunek K
    Cesk Psychiatr; 1976 Feb; 72(1):14-23. PubMed ID: 773551
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
    Otomo E; Araki G; Mori A; Kurihara M
    Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with Encephabol (author's transl)].
    Glatzel J
    Med Klin; 1976 Nov; 71(45):1958-61. PubMed ID: 792665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurements.
    Knezevic S; Mubrin Z; Risberg J; Vucinic G; Spilich G; Gubarev N; Wannenmacher W
    Int Clin Psychopharmacol; 1989 Jan; 4(1):25-38. PubMed ID: 2687355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
    Baro F; Malfroid M; Waegemans T; Cox JP
    Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of changes in hospital environment and neurotropic co-medication in chronic psychiatric inpatient. A placebo controlled double-blind study.
    Lehmann E; Kretschmar JH; Brauer H; Reinhardt B
    Pharmacopsychiatria; 1982 Mar; 15(2):57-60. PubMed ID: 7043497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
    Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyritinol hydrochloride and cognitive functions: influence on children in slow learner classes.
    Wälti U; Kuenzler M; Schild J; Vassella F; Pavlincova E; Bircher J; Herschkowitz N
    Pediatr Res; 1975 Sep; 9(9):717-21. PubMed ID: 1105370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
    Aranda B; Dumoulin P; Groothold G
    Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
    Engelmann G
    Med Welt; 1975 Jul; 26(29-30):1380-4. PubMed ID: 1100984
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
    Garweg G; Herrmann WM; Kern U
    Z Gerontol; 1987; 20(1):56-62. PubMed ID: 3554804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
    Tazaki Y; Omae T; Kuromaru S; Ohtomo E; Hasegawa K; Mori A; Kurihara M; Kutsusawa N; Okada T
    J Int Med Res; 1980; 8(2):118-26. PubMed ID: 6989681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.